Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Gerald Commissiong

Tracked across 9 events · 68 articles · First seen Jun 01, 2026 · Last active Sep 21, 2026

Sentiment
12
Attention
4
Events
9
Relationships
6
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Business
Impact: Gerald Commissiong, Interim Co-CEO of Wellgistics, provided key insights into the company's transformative period, strategic direction, and future growth plans.
Jun 01, 2026 · 7 articles
4 10
Business
Impact: Gerald Commissiong, Interim Co-CEO of Wellgistics, provided commentary on the strategic rationale behind the name change and the company's vision.
Jun 26, 2026 · 6 articles
2 10
Business
Impact: As Interim Co-CEO, Commissiong is the public face of the initiative, and his appearance on Fox Business may boost investor confidence in the company's leadership.
Aug 05, 2026 · 6 articles
2 5
Business
Impact: Gerald Commissiong, Interim Co-CEO of DataMeds AI, is the spokesperson for the rebranding and strategic initiatives.
Aug 10, 2026 · 13 articles
1 5
Business
DataMeds AI, Inc. (NASDAQ:MEDS) and Tollo Health, LLC announced a joint partnership with the NFL Players Association through its Alumni Health subsidiary. The collaboration aims to provide underserved and rural communities with access to telehealth…
Impact: As CEO of Tollo and interim co-CEO of DataMeds, Commissiong is a key spokesperson and driver of the partnership.
Sep 08, 2026 · 6 articles
1 5
Business
Impact: Gerald Commissiong, interim co-CEO, is the spokesperson for the launch, representing the company's leadership and strategic direction.
Aug 27, 2026 · 10 articles
2 0
Business
DataMeds AI, Inc. (NASDAQ:MEDS) completed the acquisition of Helomics Corporation, an artificial intelligence cancer diagnostics laboratory business, from Computex Inc. (NASDAQ:AGPU) for a total purchase value of $1.5 million. The consideration consisted of common shares…
Impact: As Interim Co-CEO of DataMEDS, Gerald Commissiong highlighted the strategic importance of the acquisition in expanding into oncology and improving patient outcomes.
Sep 15, 2026 · 7 articles
1 10
Business
DataMeds AI (NASDAQ:MEDS), a Tampa-based health IT and healthcare company formerly known as Wellgistics Health, Inc., announced on September 18, 2026 that it has settled litigation tied to outstanding debt and receivables arising from the…
Impact: Interim Co-CEO of DataMeds AI who publicly framed the settlement as clearing the way for the company's healthcare integration and tokenization strategy.
Sep 18, 2026 · 7 articles
1 0
Business
DataMeds AI, Inc. (NASDAQ:MEDS), a Tampa-based Health IT company formerly known as Wellgistics, Inc., announced on September 21, 2026 the launch of its new corporate website, www.DataMedsAI.com. The company said the updated site aligns with…
Impact: Gerald Commissiong, Interim Co-CEO of DataMeds AI, commented on the website launch, the Helomics acquisition closing, the litigation settlement, and plans to soft launch the Health Lives Here app.
Sep 21, 2026 · 6 articles
DataMeds AI co-ceo ↔ Gerald Commissiong Gerald Commissiong serves as the Interim Co-CEO of DataMeds AI, where he is acti
DataMeds AI ↔ Gerald Commissiong
Tollo Health ↔ Gerald Commissiong
Corexa Health ↔ Gerald Commissiong
Tollo Health ↔ Gerald Commissiong
Corexa Health ↔ Gerald Commissiong
ERGEN INTELLIGENCE
Track Gerald Commissiong live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.